(Q70679231)
Statements
High-dose versus intermediate dose cytosine arabinoside combined with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia: results of an age adjusted randomized comparison (English)
W Hiddemann
C Aul
G Maschmeyer
R Schönrock-Nabulsi
W D Ludwig
A Bartholomäus
P Bettelheim
K Becker
L Balleisen